We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$2.9M
Cap. Flow
-$9.1M
Cap. Flow %
-2.78%
Top 10 Hldgs %
34.51%
Holding
107
New
22
Increased
29
Reduced
23
Closed
32

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$10.3M
2
MDT icon
Medtronic
MDT
+$7.09M
3
WMGI
Wright Medical Group Inc
WMGI
+$6.55M
4
AGN
Allergan plc
AGN
+$6.46M
5
MRK icon
Merck
MRK
+$6.16M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.12M
2
UHS icon
Universal Health Services
UHS
+$7.89M
3
BIIB icon
Biogen
BIIB
+$7.83M
4
BCR
CR Bard Inc.
BCR
+$5.49M
5
NSTG
NanoString Technologies, Inc.
NSTG
+$4.77M

Sector Composition

Rank Sector Weight
1 Healthcare 86.13%
2 Real Estate 3.64%
3 Financials 2.17%
4 Technology 0.3%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVA icon
1
DaVita
DVA
$15.4B
$15.5M 4.74%
214,713
-59,510
-22% -$3.66M
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
$13.1M 4%
180,223
+145,759
+423% +$10.3M
AGN
3
DELISTED
Allergan plc
AGN
$12.5M 3.82%
76,491
+36,014
+89% +$6.46M
SBRA icon
4
Sabra Healthcare REIT
SBRA
$5.34B
$11.9M 3.64%
634,419
+78,089
+14% +$1.55M
MCK icon
5
McKesson
MCK
$100B
$11.2M 3.44%
72,100
+26,300
+57% +$3.9M
DHR icon
6
Danaher
DHR
$137B
$10.5M 3.22%
128,101
-27,411
-18% -$2.23M
MD icon
7
Pediatrix Medical
MD
$2.18B
$9.71M 2.97%
181,717
+5,317
+3% +$251K
HOLX
8
DELISTED
Hologic
HOLX
$9.53M 2.91%
222,844
+119,641
+116% +$4.77M
TVTY
9
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$9.46M 2.89%
258,757
+57,757
+29% +$2.19M
MDT icon
10
Medtronic
MDT
$109B
$9.39M 2.87%
116,315
+88,576
+319% +$7.09M
UNH icon
11
UnitedHealth
UNH
$376B
$8.52M 2.6%
38,656
+15,884
+70% +$3.37M
JNJ icon
12
Johnson & Johnson
JNJ
$618B
$8.49M 2.6%
60,800
+4,300
+8% +$599K
BSX icon
13
Boston Scientific
BSX
$69.5B
$8.49M 2.6%
342,598
+132,100
+63% +$3.64M
TMO icon
14
Thermo Fisher Scientific
TMO
$213B
$8.28M 2.53%
43,608
-16,000
-27% -$3.07M
ABT icon
15
Abbott
ABT
$183B
$8.18M 2.5%
143,383
-68,600
-32% -$3.8M
OXFD
16
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.97M 2.44%
570,425
-161,084
-22% -$2.36M
AET
17
DELISTED
Aetna Inc
AET
$7.11M 2.17%
39,427
-22,000
-36% -$3.78M
EVHC
18
DELISTED
Envision Healthcare Holdings Inc
EVHC
$6.78M 2.07%
196,174
+128,314
+189% +$4.49M
WMGI
19
DELISTED
Wright Medical Group Inc
WMGI
$6.78M 2.07%
305,200
+265,600
+671% +$6.55M
CAH icon
20
Cardinal Health
CAH
$53.9B
$6.24M 1.91%
101,771
+15,200
+18% +$940K
BBH icon
21
VanEck Biotech ETF
BBH
$400M
$6.22M 1.9%
49,899
+11,100
+29% +$1.42M
MRK icon
22
Merck
MRK
$322B
$5.97M 1.82%
+111,193
New +$6.16M
HRC
23
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$5.58M 1.71%
+66,200
New +$5.36M
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
$5.58M 1.7%
74,690
-49,100
-40% -$3.14M
PTLA
25
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.24M 1.6%
107,600
+7,200
+7% +$364K
1
2 3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Endurant Capital Management held 107 positions worth $327M, down 0.88% from $330M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Endurant Capital Management's Q4 2017 filing shows 22 new, 29 increased, 23 reduced and 32 closed positions. Its largest new stake was Merck: 111,193 shares worth $5.97M. The largest sale was Pfizer, an estimated $8.12M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 83% a quarter earlier, followed by Real Estate and Financials.

  • Endurant Capital Management's largest Q4 2017 buy was Merck: 111,193 shares worth $5.97M.
  • Endurant Capital Management added most to Walgreens Boots Alliance in Q4 2017, an estimated $10.3M increase.
  • Endurant Capital Management's biggest Q4 2017 reduction was Biogen, cutting an estimated $7.83M.
  • Endurant Capital Management fully exited Pfizer in Q4 2017, selling an estimated $8.12M.
  • Endurant Capital Management's ten largest holdings make up 35% of its $327M portfolio in Q4 2017.
  • Endurant Capital Management opened 22 new positions and closed 32 in Q4 2017.
  • Endurant Capital Management's portfolio value fell 0.88% quarter-over-quarter to $327M.

Based on Endurant Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.